|
WO2010091876A2
|
|
Small molecule bradykinin b1 receptor antagonists
|
|
TW201024275A
|
|
Small molecule bradykinin B2 receptor modulators
|
|
WO2010031577A1
|
|
Use of bradykinin b1 receptor antagonists in intestinal fibrosis treatment
|
|
AU2008300822A1
|
|
Small molecule bradykinin B1 receptor antagonists
|
|
NZ579764A
|
|
8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
|
|
TW200843767A
|
|
Small molecule bradykinin b2 receptor modulators
|
|
TW200811164A
|
|
New heterocyclic compounds for the inhibition of integrins and use thereof
|
|
EP1979342A1
|
|
Compounds for the inhibition of integrins and use thereof
|
|
AU2006205830A1
|
|
C5a receptor antagonists
|
|
EP1741444A1
|
|
Kinin antagonists for treating bladder dysfunction
|
|
EP1739078A1
|
|
Antagonists of C5a-receptor
|
|
RU2393154C2
|
|
Novel antiogenesis inhibiting compounds and use thereof
|
|
US2008194524A1
|
|
Compounds For the Inhibition of Undesired Cell Proliferation and Use Thereof
|
|
EP1498422A1
|
|
C5a Receptor Antagonists
|
|
EP1445260A1
|
|
Method of immobilising of chemical compounds to solid phases
|
|
EP1433779A1
|
|
Use of nitriles as inhibitors of non-proteolytic enzymes
|
|
EP1433778A1
|
|
Use of nitriles as rotamase inhibitors
|
|
EP1402888A1
|
|
The use of substituted carbocyclic compounds as rotamases inhibitors
|
|
EP1402887A1
|
|
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
DE10158645A1
|
|
Tub-shaped incubation vessel
|
